Publication | Open Access

Enhancement of in vivo and in vitro immune functions by a conformationally biased, response-selective agonist of human C5a: Implications for a novel adjuvant in vaccine design

VaccinationHuman C5aAllergyMedicineVaccine TargetImmunologyImmunodominanceTherapeutic VaccineAutoimmunityResponse-selective AgonistVaccine DesignPrecision VaccinologySynthetic Immunology